The future of chronic obstructive pulmonary disease treatment—difficulties of and barriers to drug development
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference137 articles.
1. Global burden of COPD: systematic review and meta-analysis;Halbert;Eur Respir J,2006
2. Projections of global mortality and burden of disease from 2002 to 2030;Mathers;PLoS Med,2007
3. Estimating the cost of new drug development: is it really 802 million dollars?;Adams;Health Aff (Millwood),2006
4. Emerging pharmacotherapies for COPD;Barnes;Chest,2008
5. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary;Rabe;Am J Respir Crit Care Med,2007
Cited by 83 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The role of pulmonary vascular endothelium in chronic obstructive pulmonary disease (COPD): Does endothelium play a role in the onset and progression of COPD?;Exploration of Medicine;2023-12-29
2. Design of a microfluidic lung chip and its application in assessing the toxicity of formaldehyde;Toxicology Mechanisms and Methods;2022-12-27
3. Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases;Future Medicinal Chemistry;2022-02
4. Drosophila Trachea as a Novel Model of COPD;International Journal of Molecular Sciences;2021-11-25
5. Comparisons of Efficacy and Safety between Triple (Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting Beta-Agonist) Therapies in Chronic Obstructive Pulmonary Disease: Systematic Review and Bayesian Network Meta-Analysis;Respiration;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3